| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.12 | 0.02 |